Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
| Actual shortage: | 246 (8%) | |
| Anticipated shortage: | 15 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-04-14 | 2024-03-22 | 189662 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-16 | 2023-08-04 | 195091 |
| APO-FROVATRIPTAN | 2.5MG | TABLET | Resolved | 2023-07-13 | 2023-07-21 | 198508 |
| APO-INDAPAMIDE 2.5MG TABLETS | 2.5MG | TABLET | Resolved | 2023-08-04 | 2023-08-18 | 201168 |
| APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-08-18 | 2023-09-28 | 202403 |
| APO-MEDROXY TABLETS | 2.5MG | TABLET | Resolved | 2023-09-07 | 2023-12-01 | 203822 |
| APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2023-11-06 | 2024-03-01 | 209363 |
| APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2023-11-17 | 2023-12-22 | 210701 |
| APO-RAMIPRIL | 2.5MG | CAPSULE | Resolved | 2024-01-05 | 2024-02-02 | 215221 |
| APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-01-05 | 2024-03-08 | 215227 |
| APO-FELODIPINE | 2.5MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-19 | 2024-02-09 | 216662 |
| APO-MIDODRINE | 2.5MG | TABLET | Resolved | 2024-02-09 | 2024-05-24 | 219162 |
| APO-LETROZOLE | 2.5MG | TABLET | Resolved | 2024-03-22 | 2024-04-12 | 223043 |
| APO-TADALAFIL | 2.5MG | TABLET | Resolved | 2024-04-19 | 2024-05-31 | 225773 |
| APO-WARFARIN | 2.5MG | TABLET | Actual shortage | 2024-05-31 | 2024-05-31 | 229419 |
| APO-CROMOLYN NASAL SPRAY | 2% | SOLUTION SPRAY | Actual shortage | 2017-08-13 | 2017-10-05 | 19051 |
| APO-FAMOTIDINE TAB 20MG USP | 20 MG | TABLET | Resolved | 2017-03-11 | 2018-09-09 | 619 |
| APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-03-11 | 2017-05-24 | 423 |
| APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2017-05-10 | 2017-06-05 | 9954 |
| APO-OXYCODONE CR | 20.0MG | TABLET (EXTENDED-RELEASE) | Resolved | 2017-10-11 | 2018-03-13 | 25304 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LISINOPRIL/HCTZ | 12.5MG 10MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1093 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
| APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60335 |
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-LISINOPRIL/HCTZ | 12.5MG 20MG | TABLET | Discontinued | 2017-03-13 | 2017-03-13 | 1090 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2018-09-07 | 2018-12-28 | 60603 |
| APO-LOSARTAN/HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71101 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40823 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-09-15 | 40826 |
| APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
| APO-CARVEDILOL | 12.5MG | TABLET | To be discontinued | 2024-01-26 | 2024-04-01 | 217493 |
| APO-DILTIAZ TZ | 120MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-03-13 | 2017-03-13 | 1064 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | 125MG 31.25MG | POWDER FOR SUSPENSION | Discontinued | 2017-03-31 | 2017-03-31 | 4903 |
| APO-AMOXI SUGAR FREE | 125MG | POWDER FOR SUSPENSION | Discontinued | 2018-09-07 | 2018-09-15 | 60246 |